MedTrace Logo

Comparison of Different Chest Compression Techniques in Infant Resuscitation

NCT07698340 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2026-07-13

No results posted yet for this study

Summary

In this prospective, single-center, randomized, self-controlled crossover manikin simulation study, participitants performed 2 minutes of single-rescuer CPR (30:2 compression-to-ventilation ratio) with each of the four techniques (the two-finger (2F), three-finger (3F), heel-of-one-hand (HOH), and two-thumb (2T) techniques) in a randomized order, with at least 10 minutes of rest between techniques. Chest compression depth, rate, release velocity, and the proportion of compressions within the target range were recorded using a feedback device. Provider fatigue and perceived difficulty (modified Borg scale) were assessed as secondary outcomes

Conditions

  • Resuscitation
  • Cardiac Arrest (CA)

Interventions

PROCEDURE

Two-Finger (2F) Technique

Participants perform single-rescuer basic life support CPR on an infant manikin for 2 minutes using the two-finger chest compression technique with a 30:2 compression-to-ventilation ratio

PROCEDURE

Three-Finger (3F) Technique

Participants perform single-rescuer basic life support CPR on an infant manikin for 2 minutes using the three-finger chest compression technique with a 30:2 compression-to-ventilation ratio.

PROCEDURE

Heel-of-One-Hand (HOH) Technique

Participants perform single-rescuer basic life support CPR on an infant manikin for 2 minutes using the heel-of-one-hand chest compression technique with a 30:2 compression-to-ventilation ratio.

PROCEDURE

Two-Thumb (2T) Technique

Participants perform single-rescuer basic life support CPR on an infant manikin for 2 minutes using the two-thumb chest compression technique with a 30:2 compression-to-ventilation ratio.

Sponsors & Collaborators

  • Ankara City Hospital Bilkent

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2025-01-01
Completion
2025-01-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07698340 on ClinicalTrials.gov